Brazilian Health Minister’s speech on compulsory licenses exposes a disconnect with the world
Adapted from a story first published by GTPI. Compulsory licensing is a vital public policy tool to combat the high...
World Hepatitis Day 2019: 1.4 million lives lost since last year
Today, 28 July, is World Hepatitis Day 2019. Since the day was marked in 2018, another 1.4 million people have...
Unitaid investment expands our work on access to medicines
ITPC is delighted to be named one of three successful grantees of a new three year investment from Unitaid to...
8 videos that explain the tension between HIV activists and Big Pharma
From Hollywood blockbusters, to investigative documentaries, to our own short, satirical animation, here are eight videos that show how the...
Fixing the broken patent system: From Marrakech and back again
Marrakech was home to the signing of the TRIPS Agreement in 1995, an agreement that has been exploited by pharmaceutical...
Storify: Pathways to Access #GSIPA2M
[View the story “Pathways to Access! #GSIPA2M (15-17 Jan 2018)” on Storify] SaveSave
GSIPA2M: The Summit Highlights
Catch up on the activity from our inaugural Global Summit on Intellectual Property and Access to Medicines (15-17 January 2018)....
GSIPA2M: Malaysia Ministry of Health 2018 winner of the Leadership Award on Intellectual Property and Access to Medicines
Malaysia’s “historic decision” to issue a compulsory license on Hep C medicine, sofosbuvir, stands up to Big Pharma, and will mean...
Malaysia paves the way for compulsory licensing on hepatitis C medicines
Historic decision will cure more hepatitis C patients – and other countries can follow suit. Today, 20 September 2017, Malaysia’s...
Tackling the hepatitis C epidemic in Malaysia
With new, revolutionary, drugs available, why isn’t everyone getting the cure? An estimated 454,000 people are living with hepatitis C...